ClinicalTrials.gg
Sign In

Biological

CHO cell clinical trials

studies test it
35
open now
7
in phase 3
13
first study started
2019

Keep track of what changes. Save the CHO cell studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Recombinant new coronavirus vaccine (CHO cell) group
5
Recombinant Zoster Vaccine (CHO Cell)
4
Recombinant two-component COVID-19 vaccine (CHO cell)
3
Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)
3
ReCOV
2

Development codes

REC610
1

Studies by the year they started

35 studies that test it; most in 2021 (11)

Studies that test CHO cell, by start year
YearStudies
20191
20205
202111
20227
20231
20242
20253
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
10
Phase 2
11
Phase 3
13
Phase 4
1
No phase
3

What it is tested for

Each study’s main condition, where its own words name it.

COVID-19
18
Herpes Zoster
6
Kidney Failure, Chronic
2
Respiratory Syncytial Virus Infections
1

Who runs them

Industry 30 · Other 5

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (12) · MAXVAX Biotechnology Limited Liability Company (5) · Jiangsu Rec-Biotechnology Co., Ltd. (5) · Ab&B Bio-tech Co., Ltd.JS (2) · National Vaccine and Serum Institute, China (2) · Guangzhou Patronus Biotech Co., Ltd. (2) · Jiangsu Province Centers for Disease Control and Prevention (2) · Shenyang Sunshine Pharmaceutical Co., LTD. (2)

Often tested with

Tested in the same studies.

CHO Cells (3) · Adjuvant (1) · Vero cell line (1)

Studies

Open first, then newest update. How each study uses CHO cell is read from its arms, and is right about nine times in ten.

Testing it · 35

See all 35 studies that test CHO cell →

Given in every arm · 1 — CHO cell is usual care beside what is tested
As the comparator · 2 — what is tested is compared with CHO cell